Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02710045Completed
Randomised, open-label trial of diphtheria + tetanus + whole-cell pertussis and measles virus vaccine live in diphtheria, Tetanus, pertussis and 1 more (3 arms), sponsored by MRC Unit The Gambia at LSHTM. Primary endpoints: Effect on Interferon (IFN)-Gamma : Interleukin (IL)-4 Ratio in Plasma at 4 weeks and Effect on CD4+FOXP3+CD127- Regulatory T Cell Frequencies at 4 weeks. Started Nov 2007; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02710045.